Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy

Marion Cornelissen, Nicole K. T. Back, David M. Burger, Petra Blom, Peter Portegies, Jan M. Prins, Marc van der Valk

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Abstract

Here, we describe a newly diagnosed HIV-1-infected patient, in whom shortly after the initiation of a darunavir-based regimen, the HIV-1 virus exclusively mutated in the cerebrospinal fluid (CSF), leading to an increase in CSF HIV-1 RNA load and neurological complaints
Original languageEnglish
Pages (from-to)931-935
JournalAntiviral therapy
Volume16
Issue number6
DOIs
Publication statusPublished - 2011

Cite this